TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
AMGN

Amgen Inc

Healthcare · Drug Manufacturers - General

414.60$ +2.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Amgen Inc (AMGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at 9,958 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow AMGN
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
823 903 1,042 1,075 1,635 1,480 2,249 3,567 3,697 4,911 5,389 5,401 5,988 6,336 5,787 5,119 5,882 6,291 8,555 9,077 10,354 11,177 11,296 9,150 10,497 9,261 9,721 8,471 11,490 9,958
100 117 144 177 212 266 447 687 734 841 963 1,202 1,073 1,049 1,017 1,060 1,088 1,286 2,092 2,108 2,105 1,955 1,946 2,206 3,601 3,398 3,417 4,071 5,592 5,167
– – 11 – – – – – – – -81 81 17 284 353 341 362 403 408 322 311 329 311 308 330 341 401 431 530 494
– – – – – – – – – 81 581 – 14 462 304 11 494 317 184 -684 526 -667 334 205 -152 3,368 485 – – –
-36 137 -4.3 -225 -121 -99 -250 443 -375 10 463 -441 427 109 -301 365 -45 -393 1,121 714 1.0 7,910 622 -731 -216 -1,194 -733 -484 2,365 -1,978
267 388 408 304 438 442 659 1,357 1,336 867 1,218 1,267 672 530 580 567 689 693 1,003 649 837 664 738 618 608 880 936 1,112 1,096 1,858
-310 -302 -674 -464 -1,036 -540 -2,864 -3,210 -1,399 -59 -5,131 -1,992 -3,165 -3,202 -4,152 -786 -9,990 -8,469 -5,752 -5,547 -8,658 -4,024 14,339 5,709 -5,401 733 -6,044 -26,204 -1,046 -1,943
– – – – – – – – – – – – – 1,980 0.0 500 1,118 1,415 1,851 2,396 2,998 3,365 3,507 3,509 3,755 4,013 4,196 4,556 4,832 5,124
-450 -738 -912 -1,025 -800 -738 -1,420 -1,801 -4,072 -4,430 -2,000 -5,100 -2,268 -3,208 -3,786 -8,315 -4,607 -832 -138 -1,867 -2,965 -3,160 -17,794 -7,702 -3,486 -4,975 -6,360 0.0 -200 0.0
– – – – – – – – – – – – – 980 2,471 7,887 4,810 4,683 -1,129 1,065 3,593 71 -1,121 -4,514 2,464 795 6,622 26,323 -3,600 -5,000
-410 -531 -406 -682 -503 -478 1,778 -1,372 -1,609 -4,538 -815 -2,668 -3,073 -2,024 -1,232 -674 419 2,726 -2,877 -3,117 -2,599 -6,594 -22,490 -15,767 -4,867 -8,271 -4,037 21,048 -9,415 -10,859
103 70 -38 -70 96 463 1,163 -1,015 689 314 -557 741 -250 1,110 403 3,659 -3,689 548 -74 413 -903 559 3,145 -908 229 1,723 -360 3,315 1,029 -2,844
556 515 634 771 1,197 1,038 1,590 2,210 2,361 4,044 4,171 4,134 5,316 5,806 5,207 4,552 5,193 5,598 7,552 8,428 9,517 10,513 10,558 8,532 9,889 8,381 8,785 7,359 10,394 8,100

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?